We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-17.52%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$678M
Cap. Flow
-$151M
Cap. Flow %
-7.77%
Top 10 Hldgs %
19.26%
Holding
283
New
21
Increased
57
Reduced
116
Closed
33

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$32.9M
2
ALKS icon
Alkermes
ALKS
+$29.9M
3
LNTH icon
Lantheus
LNTH
+$21.8M
4
ACDC icon
ProFrac Holding
ACDC
+$17.2M
5
EE icon
Excelerate Energy
EE
+$15.3M

Top Sells

Rank Stock Value
1
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
+$47M
2
PRKS icon
United Parks & Resorts
PRKS
+$27.6M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$18.6M
4
DIOD icon
Diodes
DIOD
+$16.2M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.92%
2 Technology 18.08%
3 Industrials 17.14%
4 Consumer Discretionary 14.11%
5 Financials 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
51
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$15.2M 0.78%
120,528
-134,028
-53% -$15.4M
CCOI icon
52
Cogent Communications
CCOI
$549M
$15.2M 0.78%
250,669
-11,530
-4% -$709K
FOUR icon
53
Shift4
FOUR
$3.99B
$14.9M 0.77%
451,910
+35,930
+9% +$1.7M
HLI icon
54
Houlihan Lokey
HLI
$9.67B
$14.7M 0.76%
186,198
-51,272
-22% -$4.29M
COLL icon
55
Collegium Pharmaceutical
COLL
$1.17B
$14.4M 0.74%
812,478
+12,360
+2% +$208K
PING
56
DELISTED
Ping Identity Holding Corp.
PING
$14.2M 0.73%
783,181
-51,802
-6% -$1.15M
FA icon
57
First Advantage
FA
$3.83B
$14.1M 0.73%
1,116,210
-77,303
-6% -$1.22M
ARIS
58
DELISTED
Aris Water Solutions
ARIS
$14M 0.72%
841,536
+4,912
+0.6% +$89K
EXPO icon
59
Exponent
EXPO
$3.05B
$13.7M 0.7%
+149,392
New +$14.1M
ANIP icon
60
ANI Pharmaceuticals
ANIP
$1.8B
$13.5M 0.7%
455,880
+101,835
+29% +$2.94M
TFIN icon
61
Triumph Financial Inc
TFIN
$1.92B
$13.2M 0.68%
210,410
-41,562
-16% -$2.94M
DCGO icon
62
DocGo
DCGO
$64.3M
$13.2M 0.68%
1,843,239
+518,452
+39% +$3.78M
SNCY
63
DELISTED
Sun Country Airlines
SNCY
$13M 0.67%
706,904
-48,199
-6% -$1.13M
RAMP icon
64
LiveRamp
RAMP
$2.3B
$12.6M 0.65%
487,086
-43,100
-8% -$1.28M
TMDX icon
65
Transmedics
TMDX
$2.56B
$12.5M 0.64%
397,565
+116,612
+42% +$3.11M
SMTC icon
66
Semtech
SMTC
$11.6B
$12.1M 0.62%
220,705
-162,034
-42% -$9.77M
ACAD icon
67
Acadia Pharmaceuticals
ACAD
$4.38B
$12.1M 0.62%
860,749
+72,011
+9% +$1.34M
HAYW icon
68
Hayward Holdings
HAYW
$3.12B
$12M 0.62%
837,119
+208,149
+33% +$3.21M
EE icon
69
Excelerate Energy
EE
$1.24B
$12M 0.62%
+602,658
New +$15.3M
RARE icon
70
Ultragenyx Pharmaceutical
RARE
$2.88B
$12M 0.62%
201,217
-22,735
-10% -$1.4M
HRT
71
DELISTED
HireRight Holdings Corporation
HRT
$12M 0.62%
844,832
-38,292
-4% -$597K
HRI icon
72
Herc Holdings
HRI
$4.99B
$11.9M 0.61%
131,995
-10,000
-7% -$1.2M
LOB icon
73
Live Oak Bancshares
LOB
$1.97B
$11.8M 0.61%
348,976
-116,279
-25% -$4.81M
COHR icon
74
Coherent
COHR
$54.3B
$11.7M 0.6%
229,520
+41,643
+22% +$2.54M
ARVN icon
75
Arvinas
ARVN
$517M
$11.3M 0.58%
268,256
-19,520
-7% -$979K
1 2
3
4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, Emerald Advisers held 283 positions worth $1.94B, down 26% from $2.62B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Advisers withdrew a net $151M in Q2 2022, closing 33 positions and reducing 116 holdings. Its most notable exit was Diodes, an estimated $16.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

Against the trend, Emerald Advisers opened a new position in Tandem Diabetes Care worth $23.7M.

  • Emerald Advisers's largest Q2 2022 buy was Tandem Diabetes Care: 400,931 shares worth $23.7M.
  • Emerald Advisers added most to Petco in Q2 2022, an estimated $10.9M increase.
  • Emerald Advisers's biggest Q2 2022 reduction was SailPoint Technologies Holdings, Inc. Common Stock, cutting an estimated $47M.
  • Emerald Advisers fully exited Diodes in Q2 2022, selling an estimated $16.2M.
  • Emerald Advisers's ten largest holdings make up 19% of its $1.94B portfolio in Q2 2022.
  • Emerald Advisers opened 21 new positions and closed 33 in Q2 2022.
  • Emerald Advisers's portfolio value fell 26% quarter-over-quarter to $1.94B.

Based on Emerald Advisers's 13F filing for Q2 2022, filed 29 Jul 2022.